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ABSTRACT
Manipulation of gene function in embryonic stem cells by
either over expression or downregulation is critical for
understanding their subsequent cell fate. We have devel-
oped a tetracycline-inducible short hairpin RNA interfer-
ence (shRNAi) for human embryonic stem cells (hESCs)
and demonstrated doxycycline dose-dependent knockdown
of the transcription factor OCT4 and the cell surface anti-
gen b2-microglobulin. The induced knockdown of OCT4
resulted in rapid differentiation of hESCs with a signiﬁ-
cant increase in transcription of genes associated with
trophoblast and endoderm lineages, the extent of which
was controlled by the degree of induction. Transgene tox-
icity, which may occur in conditional over-expression
strategies with hESCs, was not observed with wild-type
Tet repressor protein. The system allows efﬁcient, reversi-
ble, and long-term downregulation of target genes in
hESCs and enables the generation of stable transfectants
for the knockdown of genes essential for cell survival and
self-renewal, not necessarily possible by nonconditional
shRNAi methods. STEM CELLS 2009;27:776–782
Disclosure of potential conﬂicts of interest is found at the end of this article.
INTRODUCTION
Human embryonic stem cells (hESCs) are powerful tools for
the in vitro study of early human development, and moreover
provide a source of cells with therapeutic potential in regener-
ative medicine [1, 2]. The molecular mechanisms controlling
survival, self-renewal, and cell-fate decisions are not clearly
deﬁned, and strategies designed to control gene expression by
either loss or gain-of-function are invaluable tools for their
study. Problems associated with transfection efﬁciencies in
hESCs [3, 4] can hinder the use of transient systems to con-
trol gene expression, making the generation of stably-
expressed transgenes a favorable option. However, difﬁculties
may also arise if stably-expressed transgenes adversely regu-
late hESC survival, proliferation, or self-renewal. A solution
is to place expression of the transgene under the constraints
of an inducible mechanism. The tetracycline (Tet)-Off and
Tet-On inducible expression systems [5] are most widely used
to control transgene expression, though the Cre-ERT2 method
is also an effective means of transgene regulation [6]. Induci-
ble over expression of transgenes has been performed in
hESCs using Tet [7, 8] and Cre recombinase-based systems
[9, 10], but problems with the toxicity were encountered with
constitutively expressed Tet activator and Cre in hESCs.
RNA interference (RNAi) is now established as a power-
ful tool for speciﬁc gene knockdown in mammalian cells
[11]. One important advance has been the development of
short hairpin RNA interference (shRNAi) systems driven by
RNA polymerase III promoters [12–15]. These vector-based
approaches permit long-term knockdown cell lines to be
established, although it is only possible to use them transi-
ently in hESCs for the knockdown of self-renewal associated
genes such as OCT4 and SPA1 [4, 16, 17]. Conditional
knockdown of target genes in other mammalian cells has
been achieved using a doxycycline-inducible version of the
H1 promoter in the pSUPER vector [15], termed pSUPE-
RIOR, [18]. In this system, cells are required to express wild-
type Tet repressor (TetR) protein and not the tetracycline-
controlled transactivator protein (tTA) or the reverse tetracy-
cline-controlled transactivator (rtTA). The tTA and rtTA pro-
teins that are utilized by the Tet-Off and Tet-On systems,
respectively, are based on fusions of the TetR protein to the
transactivating domain of VP16 [19, 20]. This transactivating
domain is believed to be responsible for their toxicity in sen-
sitive hESCs.
We have now used the TetR pSUPERIOR system to gen-
erate conditional shRNAi knockdowns of target genes in
hESCs. By generating a stable hESC line constitutively
expressing TetR under the control of the pCAG promoter [21,
22], we generated clones that induced speciﬁc and dose-de-
pendent knockdown of b2-microglobulin (b2M) and OCT4.
The latter was targeted as an example of a gene required for
the self-renewal of hESCs [23]. Downregulation of OCT4
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derm [24, 25], a result that correlates with the differentiation
of hESCs subjected to OCT4 RNAi toward trophoblast and
endoderm lineage [4, 16, 26, 27]. Using our inducible
shRNAi system, we also observed dramatic differentiation of
cells following induction of OCT4 knockdown, with an
increase in expression of trophoblast and mesoderm-associ-
ated gene transcripts.
MATERIALS AND METHODS
Plasmid Construction
TetR Nuclear Localization Signal-pCAG. Wild-type TetR
cDNA, containing an N-terminus SV40 nuclear localization signal
(nls) (a kind gift of F.G. Grosveld), was excised from the pBSKS
plasmid by XhoI and NotI digestion and inserted into the XhoI
and NotI sites of pCAGeGFP [22] in which XhoI/NotI digestion
excises the green ﬂuorescent protein fragment.
pSUPERIOR-Target Hairpin. Target sequences were
designed with an online small interfering RNA (siRNA) design
tool (Ambion, Austin, TX, http://www.ambion.com). To construct
the hairpin vectors, oligonucleotides (MWG Biotech, Ebersberg,
Germany, http://www.mwg-biotech.com) were annealed by com-
bining equal volumes of the sense and antisense hairpin oligonu-
cleotides (100 lM in water). The mix was incubated in a water
bath at 95 C for 5 minutes and allowed to cool to room tempera-
ture. The annealed oligonucleotides were designed to carry BglII
and XhoI compatible overhangs enabling them to be cloned into
the BamHI, XhoI linearized vector pSUPERIOR.neo (Oligoen-
gine). Oligonucleotides were as follows:
OCT4: 50-GATCCGGATGTGGTCCGAGTGTGGTTCAA
GAGACCACACTCGGACCACATCCTTTTTTC-30 and 50-
TCGAGAAAAAAGGATGTGGTCCGAGTGTGGTCTCTT
GAACCACACTCGGACCACATCCG-30;
b2M: 50-GATCCGGACTGGTCTTTCTATCTCTTCAAGA
GAGAGATAGAAAGACCAGTCCTTTTTTC-30 and 50-TC
GAGAAAAAAGGACTGGTCTTTCTATCTCTCTCTTGA
AGAGATAGAAAGACCAGTCCG-30.
To conﬁrm that cloned fragments were of the correct
sequence, we used the following sequencing primer: 50-
AGAATTCGAACGCTGACGTC-30.
Cell Culture and Generation of Stable Transfectants
The Shef4 cell line was used throughout and exhibits standard
morphological and surface marker characteristics of hESCs and a
normal 46XY karyotype [28]. This cell line is one of several gen-
erated under license and guidelines of the Human Fertilization
and Embryology Authority at the Centre for Stem cell Biology
(University of Shefﬁeld, U.K.). Shef4 has been independently
validated and accepted by the U.K. Stem Cell Bank for distribu-
tion to the science community. hESCs were maintained in hESC
medium comprising knockout-Dulbecco’s modiﬁed Eagle’s me-
dium (DMEM) supplemented with 20% knockout serum replace-
ment, 1% nonessential amino acids, 1 mM L-glutamine, 4 ng/ml
basic ﬁbroblast growth factor (all from Invitrogen, Carlsbad, CA,
http://www.invitrogen.com), and 0.1 mM b-mercapto-ethanol
(Sigma-Aldrich, St. Louis, MO, http://www.sigmaaldrich.com) at
37 C under a humidiﬁed atmosphere of 5% CO2 in air. Cells were
passaged weekly by manual dissection: Following digestion for 5
minutes with 1 mg/ml collagenase type IV (Invitrogen), colonies
were excised using the end of a 1 ml extended ﬁne tip disposable
pipette (Alpha Laboratories, Hampshire, United Kingdom, http://
www.alphalabs.co.uk). Cells were seeded on feeder layers of
mitotically inactivated mouse embryonic ﬁbroblasts (MEFs) ( 7.2
  10
3 cells per cm
2). MEFs were grown in DMEM (Invitrogen)
supplemented with 10% heat inactivated fetal calf serum (FCS;
Invitrogen) and mitotically inactivated by incubation with 10 lg/
ml Mitomycin C (Sigma-Aldrich) for 3 hours. The FCS batch was
prequaliﬁed to be free of doxycycline and tetracycline to prevent
any nonexperimentally-induced transgene expression.
To generate stable transfected cell lines, collagenase digested
hESC colonies were broken into small clumps and recovered
from feeders by disruption in situ with 3 mm glass beads.
Approximately 1 million cells were incubated with 10 lg vector
(both TetRnls-pCAG and pSUPERIOR vectors were linearized by
ScaI) and electroporated using the EasyjecT Optima electropora-
tor (EquiBio) at 240 V, 1,050 lF, and resistance set to inﬁnity.
Transfectants were plated on mitotically inactivated MEF21 neo-
mycin/puromycin-resistant ﬁbroblasts in 10-cm
2 Nunclon D sur-
face Petri dishes (Nunc, Rochester, NY, http://www.nuncbrand.-
com). MEF21 is a spontaneously immortalized mouse ﬁbroblast
cell line derived from primary mouse ﬁbroblasts derived in house
and subsequently stably transfected to express G418 and puromy-
cin resistance markers (data not published). Colonies of trans-
fected cells were allowed to establish for 4-6 days of culture
before antibiotic selection. TetRnls-pCAG transfectants were
selected with hESC medium containing puromycin (Sigma-
Aldrich) at 1 lg/ml and pSUPERIOR transfectants with G418
(Invitrogen) at 10 mg/ml. Once stable transgene expressing clones
were generated, they were cultured on regular MEFs in hESC
medium without antibiotics. Karyotype analysis was performed
routinely to conﬁrm euploidy of transfectants, using standard G-
banding techniques as described previously [29].
Northern Blotting Analysis
Northern analysis was performed to conﬁrm hairpin transcription
[30]. The sequences of the probes were as follows:
Transfer RNA valine (loading control): 50-GAACGTGAT
AACCACTACACTACGGAAACCCTATAGTGAGTCGTAT
TAGGCGGGAACCGCCTAATACGACTCACTATAGG-30;
OCT4: 50-GGATGTGGTCCGAGTGTGG-30.
Immunoblotting
Cells were lysed by sonication in ice cold phosphate buffered sa-
line containing 1% Nonidet P-40, 0.5% sodium deoxycholate,
0.1% SDS, 1 mM DL-dithiothreitol, 1 mM EDTA, 4 mM Na3V04,
4 mM NaF, 1 mM phenylmethylsulfonyl ﬂuoride, 1  ﬁnal con-
centration Complete Protease inhibitor (Roche Diagnostics, Basel,
Switzerland, http://www.roche-applied-science.com). Fifteen
micrograms of extracted protein was fractionated by sodium do-
decyl sulfate polyacrylamide gel electrophoresis on a 12.5% ac-
rylamide gel and electroblotted onto a polyvinylidene diﬂuoride
membrane (Amersham Biosciences, Piscataway, NJ, http://
www.amersham.com). Membranes were stained with either of the
following antibodies: ab6276, anti-b-actin (Abcam, Cambridge,
U.K., http://www.abcam.com), sc-9081, anti-Oct3/4 (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, http://www.scbt.com) or
TET-02, anti-TetR (MoBiTec, Go ¨ttingen, Germany, http://
www.mobitec.de), with sc-2005, goat anti-mouse and sc-2955,
chicken anti-rabbit horseradish peroxidase (HRP)-conjugated sec-
ondary antibodies (Santa Cruz). HRP was detected using Super-
signal West Pico chemiluminescent substrate (Pierce, Rockford,
IL, http://www.piercenet.com) and visualized with Hyperﬁlm
ECL ﬁlm (Amersham Biosciences).
Immunocytochemistry
Cells were ﬁxed with 4% paraformaldehyde for and permeabil-
ized using buffer containing phosphate buffered saline (PBS),
10% FCS, and 0.1% Triton X-100. Staining was performed using
sc-5279, mouse monoclonal anti-Oct3/4 (Santa Cruz) and anti-
body localization was determined by M30801, Goat anti-mouse
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secondary antibody (Caltag Laboratories, Carlsbad, CA, http://
www.invitrogen.com). Fluorescence was detected using an Olym-
pus CKX41 microscope, and images were captured using a Nikon
DS-L1 camera.
Flow Cytometry
Single cells were harvested by trypsinization and resuspended in
wash buffer (PBS with 5% FCS), and 100 ll aliquots containing
1   10
5 cells were incubated with primary antibody for 1 hour.
P3X63Ag8 (negative control) [31], anti-stage-speciﬁc embryonic
antigen-3 (SSEA3) [32], and TRA-1-60 [33] antibodies were
derived in-house from hybridoma supernatants as described ear-
lier [34]. After washing by centrifugation, cells were incubated
with goat anti-mouse IgG þ IgM (H þ L) FITC-conjugate (Cal-
tag Laboratories) at 1:200 for 1 hour and analyzed after washing
by ﬂow cytometry using an ADP CyAn cytometer (Beckman
Coulter, Fullerton, CA, http://www.beckmancoulter.com).
Reverse Transcription-Polymerase Chain Reaction
For standard reverse transcription-polymerase chain reaction (RT-
PCR) procedures, total RNA was extracted using TRIzol Reagent
(Invitrogen) and DNAseI treated using the TURBO DNA-free kit
(Ambion). For real time RT-PCR procedures, total RNA was
extracted using the RNeasy Plus Mini Kit (Qiagen, Hilden, Ger-
many, http://www1.qiagen.com) and QIA shredder (Qiagen).
cDNA was synthesized using RevertAid H Minus M-MuLV
Reverse Transcriptase (Fermentas, International Inc., Ontario, Can-
ada, http://www.fermentas.com) and primers oligo-dT [16] and
oligo-dN [6]. Taq DNA polymerase (Invitrogen) was used to
amplify cDNA products, which were fractionated on 2% Tris/
Borate/EDTA agarose gel and visualized under a UV source follow-
ing ethidium bromide (Sigma-Aldrich) staining. Band intensities
were analyzed using GeneTools software v3.07 (SynGene, Cam-
bridge, United Kingdom, http://www.syngene.com). Ampliﬁcation
for real time RT-PCR was performed using SYBR Green JumpStart
Taq ReadyMix (Sigma-Aldrich) and an iCycler (Bio-Rad, Hercules,
CA, http://www.bio-rad.com) for signal detection. Expression of
speciﬁc genes was compared with that of hypoxanthine-guanine
phosphoribosyl transferase using the Genex algorithm (Bio-Rad)
based on the DDCt method [35]. An annealing temperature of 58 C
was used in all reactions, using primers listed in Table 1.
RESULTS
The Shef4 TetR5 hESC Line Constitutively
Expressed TetR Protein
To generate a hESC line constitutively expressing TetR pro-
tein, Shef4 cells were transfected with the pCAG-TetRnls
construct (Fig. 1A). Following selection with puromycin, indi-
vidual clones were expanded and assessed for expression of
TetR protein and also for OCT4, indicative of an undifferenti-
ated phenotype (Fig. 1B). Because TetR protein is required
for the transcriptional block of hairpin synthesis in this sys-
tem, it was desirable to select a clone with strong expression
of TetR to impair the possibility of leaky expression. Of the
eight clones initially selected, clone 5 (Shef4 TetR5) was
found to highly express both TetR and OCT4 and was used in
subsequent studies. The cell line had similar growth character-
istics to the parent line and on differentiation as embryoid
body displayed increased expression for genes associated with
the three germ layers (supporting information Fig. 1).
Inducible Knockdown of OCT4 in Shef4 TetR5 Cells
Shef4 TetR5 cells were transfected with the pSUPERIOR vec-
tor, into which the OCT4 target hairpin sequence had been
cloned (pSUPERIOR-OCT4), and selected with G418. Twenty
clones were screened by RT-PCR for effective OCT4 knock-
down following treatment with doxycycline. From this screen,
three clones provided >80% knockdown (data not shown).
The clone that provided the strongest knockdown was used in
all subsequent experiments.
Northern blot analysis of OCT4 hairpin RNA expression
conﬁrmed that the system was active and was induced by the
addition of doxycycline to the cells (Fig. 2A). At 0 hours,
OCT4 hairpin was undetectable, present in low amounts after
0.5 hours, and steadily increased over 8 hours. This production
of the hairpin RNA translated into efﬁcient knockdown of
OCT4 protein (Fig. 2B, 2C), as indicated by greatly reduced
OCT4 levels in whole cell extracts taken from OCT4-shRNAi
clone cells induced for 3 days with doxycycline (Fig. 2B) and
by immunocytochemistry in which OCT4 protein is undetected
following 5 days doxycycline treatment (Fig. 2C). Maximal
knockdown of OCT4 at the RNA level was achieved when
using doxycycline in excess of 1 ng/ml (data not shown), but
the degree of knockdown could be easily manipulated at lower
concentrations (Fig. 3A, 3B); the level of induced knockdown
was most sensitive between 0.01 and 0.1 ng/ml doxycycline.
Knockdown of the target OCT4 transcripts was also time
dependant. A substantial reduction in OCT4 was apparent af-
ter 48 hours, while maximal knockdown occurred at 3 days
(Fig. 3C, 3D). OCT4 transcript levels still remained com-
pletely suppressed 3 days after removal of doxycycline, con-
sistent with the tight linkage of OCT4 expression to the dif-
ferentiation state of hESCs, the effect of knocking down
OCT4 being to induce hESC differentiation. As a target gene
control, we carried out an equivalent knockdown using a
b2M-shRNAi hESC clone (Fig. 3E); b2M was selected as it
Table 1. Primers used in polymerase chain reaction
HPRT Sense: 50-CGTGGGGTCCTTTTCACCAGCAAG-30;
Antisense: 50-AATTATGGACAGGACTGAACGTC-30
b2M Sense: 50-cgctactctctctttctggc-30;
Antisense: 50-TTCACACGGCAGGCATACT-30
OCT4 Sense: 50-CGACCATCTGCCGCTTTGAG-30;
Antisense: 50-CCCCCTGTCCCCCATTCCTA-30
NANOG Sense: 50-TGGCGCGGTCTTGGCTCACTG-30;
Antisense: 50-GCCTCCAATCCCAAACAATACGA-30
CRIPTO Sense: 50-CGATGCTAACGCCTCTTTTC-30;
Antisense: 50-AGCAGCAGCCTTTACTGGTC-30
REX1 Sense: GCTGACCACCAGCACACTAGGC-30;
Antisense: TTTCTGGTGTCTTGTCTTTGCCCG-30
FOXA1 Sense: 50-CACAGGGCTGGATGGTTGTA-30;
Antisense: 50-ATGTTGCCGCTCGTAGTCA-30
GCM1 Sense: 50-GCCAAATCCAGCGGGTAATCT-30;
Antisense: 50-AGGACACAGGTTCAGAAGCAT-30
CDX2 Sense: 50-CCTCCGCTGGGCTTCATTCC-30;
Antisense: 50-TGGGGGTTCTGCAGTCTTTGGTC-30
HCGb Sense: 50-ATGGGCGGGACATGGGCATCCA-30;
Antisense: 50-GGCCCCGGGAGTCGGGATGG-30
AFP Sense: 50-AGAACCTGTCACAAGCTGTG-30;
Antisense: 50-GACAGCAAGCTGAGGATGTC-30
e-GLOBIN Sense: 50-GATGAATGTGGAAGAGGCTGG-30;
Antisense: 50-GGTGAACTCCTTGCCAAAGT-30
NEUROD1 Sense: 50- GCCCCAGGGTTATGAGACTA-30;
Antisense: 50- GTGAGTCCTCCTCTGCGTTC-30
NKX2.5 Sense: 50-CCTCAACAGCTCCCTGACTC-30;
Antisense: 50-CTCATTGCACGCTGGATAAT-30
COL2A1 Sense: 50-GTGTCAGGGCCAGGATGT-30;
Antisense: 50-CATCAAATCCTCCAGCCATC-30
Abbreviations: AFP, alpha-fetoprotein; b2M, b2-microglobulin;
HPRT, hypoxanthine-guanine phosphoribosyl transferase.
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b2M transcript downregulation also showed steady downregu-
lation up to 3 days exposure to doxycycline. In this case, it
was possible to restore b2M transcript levels following the re-
moval of doxycycline from the culture (Fig. 3E). However,
b2M expression only returned to control levels 6 days after
the end of doxycycline treatment, which may reﬂect the half-
life of the hairpin, or the time for doxycycline to be cleared
from the system, as it is active at very low levels.
Knockdown of OCT4 by Inducible shRNAi Induces
Differentiation of hESCs
Doxycycline-induced OCT4 knockdown in hESCs resulted in
their ﬂattened and more loosely packed appearance (Fig. 4A),
which correlated with reduced expression of SSEA3 and TRA-1-
60 pluripotent antibody markers (Fig. 4B) and molecular markers
NANOG, CRIPTO, and REX1. In contrast, increasing expression
was seen for transcripts of trophoblast-associated factors, GCM1,
CDX2, and HCGb when the level of OCT4 was reduced in
response to increased (0-1 ng/ml) doxycycline supplementation
(Fig. 4D). Likewise, there was increased expression of extraem-
bryonic endoderm and mesoderm-associated genes FOXA1 (for-
mally HNF3a), alpha-fetoprotein, and e-GLOBIN. Doxycycline
treatment of b2M-shRNAi cells induced efﬁcient knockdown of
b2M; however, this did not result in modiﬁcation of OCT4
expression or the expression of genes associated with differentia-
tion. These results demonstrate that transcription of markers
from both extraembryonic and trophoblast lineages increased by
induced OCT4 knockdown, and that the extent of induction can
be regulated by the degree knockdown.
DISCUSSION
Our results show that long-term target gene downregulation
can be effectively achieved by inducible shRNAi in hESCs,
in a time- and dose-dependent fashion with minimal effect on
the phenotype of the undifferentiated hESC cultures in the ab-
sence of the inducer. By targeting OCT4, a graded response in
the degree of differentiation toward trophoblast and extraem-
bryonic lineage was achieved, which was related to the degree
of OCT4 suppression. The data support previous OCT4 knock-
down studies, performed on hESCs by transient siRNA and
shRNAi [4, 16, 26, 27]; however, the inducible system offers
tight control over the level of OCT4 knockdown. By manipu-
lating the concentration of doxycycline, the degree of differen-
tiation could be modulated, as reﬂected by the expression level
of speciﬁc factors. We also observed an inverse correlation
between the degree of induced OCT4 knockdown and the
expression of FOXA1, a transcription factor involved in the
differentiation of ESCs toward endoderm [36]. This is consist-
ent with evidence that OCT4 binds directly to the nuclear bind-
ing site of the transcription factor FOXD3, so repressing its
transcriptional activation of FOXA1 [37]. Thus, as levels of
OCT4 were reduced, more FOXD3 was free to drive the
expression of FOXA1 and promote endodermal differentiation.
Although siRNA provides a simple system for target gene
knockdown, whereby cells can be transfected in situ with syn-
thetic RNAi molecules, the transfection efﬁciency of these sys-
tems in hESCs is low, though improvements have been made
using nucleofection [4]. Nevertheless, even with high efﬁciency
transfection, the cell population remains heterogeneous, making
detailed analyses difﬁcult. During our generation of inducible
shRNAi clones, there was also a high degree of variation in
knockdown between stable clones of the same target sequence
(data not shown), most likely due to the number of copies of
the shRNAi constructs integrated into individual clones, or to
positional effects. However, after picking and expanding spe-
ciﬁc clones, the inducible system provides for reproducible
knockdown that is consistent throughout the culture. Moreover,
by generating robust clones that are inducible for transgene
expression, direct comparisons can be made between cells from
the same starting population. This is particularly important
when studying hESCs due to the heterogeneity between cultures
that arises during even routine passaging.
Constitutive shRNAi has been used previously to study
the effect of suppressing OCT4 and SPA-1 (implicated in
Figure 1. TetR-based inducible short hairpin RNA interference system. (A): Graphical overview of the system (based on tetracycline [Tet] sys-
tems manual; www.clonetech.com). Constitutively expressed TetR protein binds to the TO sequence within the H1 promoter, blocking expression
of the target sequence hairpin. On addition, doxycycline binds to TetR protein, resulting in a conformational change that renders the TetR unable
to bind the TO element, and so hairpin transcription is uninhibited. Following removal of doxycycline from the system, the process is reversed,
and inhibition of hairpin transcription is restored. (B): Immunoblot analysis of eight Shef4 TetR subclones for Tetr expression. OCT4 protein
was also stained as a marker of the undifferentiated state. The TetR5 clone was chosen as it demonstrated high expression of both TetR and
OCT4. Abbreviations: TetR, tet repressor; TO, tet operator.
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necessarily transient as the hESCs were lost to differentiation
before stable clones could be generated. By using the induci-
ble shRNAi system, we have successfully generated a clone
that has been cultured in excess of 50 passages, which has
retained a normal karyotype, and is primed for efﬁcient OCT4
knockdown by the addition of doxycycline. As the timing of
the gene manipulation can be controlled, it is possible to
manipulate gene regulation at any speciﬁc developmental
stage. Furthermore, although OCT4 knockdown could not be
reversed because of the differentiation that resulted, we were
able to resume b2M expression in the b2M knockdown clones
by removal of doxycycline, illustrating the potential to switch
gene expression on and off in a development stage-speciﬁc
manner.
Although other Tet expression based inducible systems
have been used both in mouse and human ESCs, there were
problems with toxicity [8, 38, 39]. This most likely relates to
the tTA and rtTA transgenes, which were formed by the
fusion of the TetR to the transactivating domain of VP16
from Herpes simplex virus. Because our system utilized the
wild-type TetR alone without the added transactivating do-
main, there was no obvious toxicity when generating TetR
transgenic clones. Transgene silencing is also an obstacle
when generating long-term stable clones [22, 40], most likely
due progressive silencing of the transgene promoter through
prolonged culture. We therefore utilized the pCAG promoter
Figure 3. OCT4 target downregulation is dose- and time dependant.
(A): Reverse transcription-polymerase chain reaction (RT-PCR) anal-
ysis of OCT4 and HPRT (loading control) was performed on cells
cultured for 3 days with varying concentrations of dox. (B): These
data are represented graphically and show a steady decrease in OCT4
expression with increasing concentrations of dox. (C): Time trial
analysis of OCT4 expression by RT-PCR following treatment with
dox. After 3-days time point dox was removed form the culture. (D):
Graphical representation of the RT-PCR data showing maximal
knockdown between 2 and 3 days of induction. Following removal of
dox, OCT4 expression does not revive due to irreversible differentia-
tion of cell cultures. (E): Real time RT-PCR analysis of b2M expres-
sion in b2M-shRNAi clone cells, using HPRT as the reference gene
control. Cells were cultured for up to 3 days with dox and a further 6
days in the absence of dox, showing recovery of b2M expression. t
test analysis was performed against dox untreated cells. *, p > .05;
**, p > .005. Abbreviations: b2M, b2-microglobulin; d, day; dox,
doxycycline; HPRT, hypoxanthine-guanine phosphoribosyl transfer-
ase; hr, hour.
Figure 2. Induction of OCT4-speciﬁc hairpin transcription results in
OCT4 knockdown. (A): Northern blot showing expression of OCT4-
speciﬁc RNA hairpins following addition of dox to the culture. (B):
Whole cell lysates of Shef4 TetR5 OCT4-shRNAi cells were stained
for OCT4 and b-actin (loading control) following 3 days  /þ dox.
(C): OCT4-shRNAi interference cells were cultured for 5 days in the
absence (top panels) or presence (lower panels) of 5 ng/ml dox.
Expression of OCT4 (right panels) is severely reduced by culture
with dox. Scale bar:  250 lm. Abbreviations: dox, doxycycline;
shRNAi, short hairpin RNA; tRNA, transfer RNA.
780 Inducible shRNAi in hESCsto drive expression of the TetR transgene, a promoter that we
have previously shown to retain the expression of eGFP over
120 passages [22]. We found that cells maintained expression
of TetR in excess of 100 passages following the withdrawal
of puromycin selection.
SUMMARY
The tet-inducible shRNAi system that we have described and
illustrated using OCT4 and b2M knockdown provides a tool
Figure 4. OCT4 downregulation results in cell differentiation and a dose-dependant increase in transcription of lineage speciﬁc genes. (A): Phase
contrast images of Shef4Tetr5 OCT4-shRNAi colonies showing morphological differentiation following doxycyline-induced downregulation of OCT4.
Images were taken of colonies 3 days (I, II) and 7 days (III, IV) p o s t s e e d i n gi nt h ea b s e n c e(I, III) or presence (II, IV) of doxycyline. White bars:
 500 lm. (B): Flow cytometric analysis of day 7 cultures from noninduced and dox-induced cells shows OCT4 knockdown results in loss of stem
cell surface marker expression. The percentage of cells expressing surface markers of the undifferentiated state SSEA3 and TRA-1-60 was signiﬁcantly
reduced (*, p > .05; **, p > .005) following dox-induced OCT4 downregulation. Results are taken from three separate experiments. (C): Real-time
reverse transcription-polymerase chain reaction analysis showing reduced transcription of pluripotency associated genes in OCT4 knockdown cells. (D):
b2M-shRNAi Shef4 cells were cultured for 7 days in absence or presence of dox at 1 ng/ml and OCT-shRNAi Shef4 cells in the presence of doxcycy-
line from 0 to 1 ng/ml. RNA samples prepared from the cells were used for real time PCR analysis against a panel of genes expressed in differentiated
cells types. b2M knockdown was also conﬁrmed in the b2M-shRNAi cells. Data are relative to the samples from 0 ng dox, using hypoxanthine-gua-
nine phosphoribosyl transferase as a reference gene. t test analysis was performed against relevant dox untreated cells. *, p > .05; **, p > .005. Abbre-
viations: dox, doxycycline; shRNAi, short hairpin RNA interference; SSEA3, stage-speciﬁc embryonic antigen-3.
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www.StemCells.comby which the levels of speciﬁc genes can be regulated robustly
in hESCs, directly controlled by the level of induced knock-
down. Furthermore, the regulation is reversible. It is a tool that
could facilitate the detailed dissection of regulatory systems in
the inevitably complex signaling environment that exists in
hESC cultures and thereby assist elucidation of the mechanisms
that control hESC self-renewal and differentiation.
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